Aspire-Lakewood Holdings ASBP
NASDAQ ASBP
$8.80 +0.28 (+3.35%)
As of: Nov 11, 2026 · 3:59 PM EST

Aspire-Lakewood Holdings (ASBP) EBT Margin (2025 - 2026)

Updated

Aspire Biopharma Holdings' EBT Margin was -2009.61% in Q2 2026, up 9357.42 percentage points from the prior quarter.

Analysis

Aspire-Lakewood Holdings (ASBP) EBT Margin (2025 - 2026) Analysis & Trends

On a trailing twelve-month basis, Aspire Biopharma Holdings' EBT Margin was -15563.75% through Jun 30, 2026; for FY2025, it came in at -394725.06%.

  • Per Business Quant data, ASBP's EBT Margin in the three quarters before Q2 2026 was -11367.02% (Q1 2026), -189692.96% (Q4 2025) and -135268.16% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 34.46%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 0.13%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 27.75%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 30.74%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 26.27%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 45.21%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 36.90%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 20.41%
10 Aspire-Lakewood Holdings 63.98 Mn 43.01 Mn -30,086.00 -2,009.61%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -2,009.61%
Mar 31, 2026 -11,367.02%
Dec 31, 2025 -110,484.25%
Sep 30, 2025 -95,337.09%
API Access

Aspire-Lakewood Holdings EBT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebt-margin&ticker=ASBP&period=max&api_key=YOUR_API_KEY